Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Norway ,Iceland ,Liechtenstein ,Switzerland ,Swiss ,Vifor Pharma ,Iris Francesconi ,Klaus Henning Jensen ,Annie Spinetta ,Nathalie Ponnier ,Joana Goncalves ,Instagram ,Linkedin ,Twitter ,International Journal Of Nephrology ,Nasdaq ,Cara Therapeutics Inc ,Vifor Pharma Group ,European Union ,National Registry Study ,Swiss Stock Exchange ,Drug Administration ,European Commission ,Global Head Corporate Communications ,Swiss Exchange ,Exchange Commission ,Fresenius Medical Care ,Vifor Fresenius Medical Care Renal Pharma ,Cara Therapeutics ,Chief Medical Officer ,Pharma Group ,Sanifit Therapeutics ,Registry Study ,Private Securities Litigation Reform Act ,Annual Report ,Dialysis Outcomes ,Practice Patterns ,Nephrol Dial ,International Journal ,Patient Reported Outcomes ,Uremic Pruritus ,Clinj Am Soc ,Business ,Health ,Dialysis ,Europe ,Kidney Disease ,Globe Newswire ,